In academia a wide-ranging discussion about open access is weakening academic journals' monopoly on profiting from publishing research findings. Different interest groups view this differently, of course. Meanwhile, as the publishing landscape changes, are academic authors, who have long abandoned claims to copyright on many of their scholarly articles (in the "public or perish" world of university faculty-making), less docile about publishing rights, with tenured faculty positions scarcer and scarcer? This round-up of relevant pieces starts with a possible break in the pattern:
• New PLOS pricing test could signal end of scientists paying to publish free papers (Jeffrey Brainard, Science, 10-15-2020) "PLOS, the nonprofit publisher that in 2003 pioneered the open-access business model of charging authors to publish scientific articles so they are immediately free to all, this week rolled out an alternative model that could herald the end of the author-pays era. One of the new options shifts the cost of publishing open-access (OA) articles in its two most selective journals to institutions, charging them a fixed annual fee; any researcher at that institution could then publish in the PLOS journals at no additional charge."
• Want to know if an article is freely available? To check for open access, see
---PLOS ONE (covers primary research from any discipline within science and medicine)
---Paperity (the first multidisciplinary aggregator of Open Access journals and papers)
• A New Kind of ‘Big Deal’ for Elsevier (Lindsay McKenzie, Inside Higher Ed, 11-22-19) Carnegie Mellon University has signed an open-access deal with Elsevier -- the first of its kind for the publisher in the U.S. Elsevier struck a similar deal with a consortium of Norwegian research institutions earlier this year.
• Elsevier Mutiny: Cracks Are Widening in the Fortress of Academic Publishing (Mathew Ingram, Forbes, 11-2-15) "All six editors and the entire editorial board of the well-respected linguistics journal Lingua have resigned to protest the company’s failure to embrace open access. Read More